Refreshing results…
Can "specific" OCT1 inhibitors be used to determine OCT1 transporter activity toward imatinib?
Download from www.bloodjournal.orgCYP3A4*22 genotype and systemic exposure affect paclitaxel-induced neurotoxicity
Download from clincancerres.aacrjournals.orgEvaluation of Patient Enrollment in Oncology Phase I Clinical Trials
Download from theoncologist.alphamedpress.orgA pharmacogenetic predictive model for paclitaxel clearance based on the DMET platform.
Download from clincancerres.aacrjournals.orgThe kinase RSK2 modulates the sensitivity of ovarian cancer cells to cisplatin
Download from www.researchgate.netInfluence of Smoking on the Pharmacokinetics and Toxicity Profiles of Taxane Therapy
Download from clincancerres.aacrjournals.orgmiR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells
Download from www.researchgate.netRecruitment of the Major Vault Protein by InlK: A Listeria monocytogenes Strategy to Avoid Autophagy
Download from dx.doi.orgDrug transporters of platinum-based anticancer agents and their clinical significance
Download from www.researchgate.netDrug Transporters and Imatinib Treatment: Implications for Clinical Practice
Download from clincancerres.aacrjournals.orgMissing publications? Search for publications with a matching author name.